The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)
The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)
Recruiting · NCT07556107 · Registry updated 2026-08-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Inflammation, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, Urogenital Diseases, acute kidney injury, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 4 | 2026-08-18 | NCT07556107 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bassett Healthcare | 2 |
| Johns Hopkins University | 579 |
| Patient-Centered Outcomes Research Institute | 213 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Bassett Medical Center | Cooperstown | United States | 6 |
| Wake Forest University Health Sciences | Winston-Salem | United States | 330 |
| West Virginia University | Morgantown | United States | 87 |